32366-02-2

Basic information

• Product Name: Carbamic chloride, methyl(phenylmethyl)-
• CAS NO: 32366-02-2
• Molecular Formula: C9H10ClNO
• Molecular Weight: 183.637
• Mol File: 32366-02-2.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Carbamic chloride, methyl(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic chloride, methyl(phenylmethyl)-(32366-02-2)
• EPA Substance Registry System: Carbamic chloride, methyl(phenylmethyl)-(32366-02-2)

Safety Data

• Hazardous Substances Data: 32366-02-2(Hazardous Substances Data)

Upstream product

• 75-44-5 phosgene 
• 13426-94-3 N-methylbenzylamine hydrochloride 
• 32315-10-9 bis(trichloromethyl) carbonate 
• 103-67-3 benzyl-methyl-amine 

Downstream Products

• 62899-58-5 benzyl-methyl-carbamic acid-(3-dimethylamino-phenyl ester) 
• 56964-66-0 N,N’-dimethyl-N,N’-dibenzylurea 
• 1356960-60-5 N-benzyl-N-methyl-4-(pyridin-3-yl)-1H-imidazole-1-carboxamide 
• 800393-36-6 C₁₉H₁₉BrN₄O₃ 
• 800393-37-7 C₁₉H₁₇Br₃N₄O₃ 
• 1239326-96-5 benzyl(methyl)carbonocyanidic amide 
• 1324007-53-5 [N-(tert-butoxycarbonyl)-N'-(N-benzylcarbamoyl-N-methyl)]-1H-pyrazole-1-carboxamidine 
• 736993-85-4 2-oxo-4-[(2-trimethylsilanyl-ethanesulfonyl)-(5-trimethylsilanyl-1H-pyrrole-2-carbonyl)-amino]-4,6a-dihydro-3aH-cyclopentaoxazole-3-carboxylic acid benzyl-methyl-amide 
• 736993-87-6 2-oxo-4-[(5-trimethylsilanyl-1H-pyrrole-2-carbonyl)-amino]-4,6a-dihydro-3aH-cyclopentaoxazole-3-carboxylic acid benzyl-methyl-amide 
• 736993-91-2 5-Trimethylsilanyl-1H-pyrrole-2-carboxylic acid [(1R,4R,5S)-5-(3-benzyl-3-methyl-ureido)-4-hydroxy-cyclopent-2-enyl]-amide 
• 736993-75-2 5-Trimethylsilanyl-1H-pyrrole-2-carboxylic acid [(1R,5S)-5-(3-benzyl-3-methyl-ureido)-4-oxo-cyclopent-2-enyl]-amide 

Relevant articles and documents

INHIBITORS OF ALPHA 2 BETA 1 INTEGRIN AND METHODS OF USE THEREOF

Disclosed herein, inter alia, are inhibitors of alpha 2 beta 1 integrin and methods of using the same.

Cannabidiol carbamate compound, pharmaceutical preparation, preparation method and application

The invention relates to a cannabidiol carbamate compound, a medicinal preparation, a preparation method and application, and belongs to the field of compounds for treating and preventing diseases related to aging, Alzheimer's disease and Parkinson's disease. The compound has a structure shown as a formula I or a pharmaceutically acceptable salt of the structure shown as the formula I. The compound has good butyrylcholine esterase resisting activity, shows good application prospect in treatment of Alzheimer's disease, and shows good application potential.

STING PYRAZOLE AGONISTS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the modulation of STING, and the treatment of STING-mediated disorders.